Stanley Kolis (Eli Lilly & Company )
"Synthesis of LY2603618, A Heterocyclic Anti-Cancer Compound"
Stanley is a 1992 Chemistry alumnus
Calendars
- All Events
- Biochemistry Seminar
- Biophysics Seminar
- (CBBI) Chemistry, Biochemistry, Biology Interface Program
- Departmental Colloquium
- Heidelberg at Notre Dame
- IMPACT Lecture Series
- Inorganic Seminar
- J.P. Freeman Lectureship
- Nieuwland Lecture
- Organic Seminar
- Physical/Analytical Seminar
- Reilly Lecture
- Special Seminar